Gå till Affärer
Hälsovård

Kungshusen Medicinska has been acquired by Diploma

Kungshusen Medicinska AB has been acquired by Diploma PLC. Through the acquisition, Diploma gains access to a unique platform for the distribution of medtech products in Sweden.

Founded in 1977, Kungshusen is a leading Swedish distributor of medtech products in endoscopy and diathermy. The company has established a solid supplier network comprising leading international manufacturers of high-quality products and has built a strong reputation in the market based on its one-stop shop offering, high deliverability and vast sector experience. Headquartered in Mariefred, Kungshusen serves healthcare providers in all major regions of Sweden. Kungshusen’s revenues amount to approximately US$14 million.

Diploma is a UK-listed international group supplying specialized products and services within seals, controls and life sciences. Within the life sciences segment, the company supplies clinical diagnostics instruments and surgical medical devices to hospitals, clinics and laboratories, primarily in Canada, Europe and Australia. Diploma’s revenues amount to approximately US$740 million.

Oaklins’ Swedish team was engaged to run a structured sale process and advised the seller throughout the transaction.

“We are delighted to have found the right new owner of Kungshusen that will leverage the company platform to further expand the business in the future. The Oaklins team has given us excellent support throughout the whole transaction with their professionalism and dedication.”

Henrik Svärdskog

CEO and Co-owner, Kungshusen Medicinska AB

Prata med transaktionsteamet

Adel Koubaa

Managing Partner
Stockholm, Sverige
Oaklins Sweden

Lars Gustafsson

Partner
Stockholm, Sverige
Oaklins Sweden

Christos Karabelas

Associate Director
Stockholm, Sverige
Oaklins Sweden

Relaterade affärer

Afric Phar has been acquired by Pharma Capital
Hälsovård

Afric Phar has been acquired by Pharma Capital

Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.

Lär dig mer
Xiel Limited has been acquired by MIS Healthcare
Riskkapital | Hälsovård

Xiel Limited has been acquired by MIS Healthcare

MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.

Lär dig mer
Bayer AG has entered into a takeover agreement with Cara Care
Hälsovård | TMT

Bayer AG has entered into a takeover agreement with Cara Care

Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.

Lär dig mer